Newsroom

The Adwardees (from left): Tobias May, Dagmar Wirth, Tom Wahlicht, Roland Schucht

News

Scientists from InSCREENeX GmbH and the Helmholtz Centre for Infection Research (HZI) have collaborated to develop a technology allowing cells from any tissue to be proliferated in a petri dish without losing the cells' tissue-specific properties. For example, this allows for newly discovered agents to be selectively tested in the cell culture and it provides the ability to examine organ-specific effects. In the meantime, the researchers have fine-tuned their process to the point where only a small number of cells is required as the starting material. Today, the Chamber of Industry and Commerce Braunschweig honoured this technology with the 2018 Technology Transfer Award. The award is endowed with 10,000 euros and goes to Dr Tobias May, Dr Roland Schucht and Dr Tom Wahlicht from InSCREENeX, as well as Prof Dagmar Wirth, who is the head of the "Model Systems for Infection and Immunity" research group at the HZI.

02.11.2018

HZI Campus

Interview

On average, every adult in Germany suffers from up to three respiratory infections per year. Although mostly caused by viruses, these infections are sometimes incorrectly treated with antibiotics. Dr. Stefanie Castell, deputy head of the HZI Department of Epidemiology, talks about a training project called WASA (“Wirksamkeit von Antibiotika-Schulungen in der niedergelassenen Ärzteschaft” – effectiveness of trainings on antibiotic prescription in primary care) that should improve the handling of antibiotic prescriptions.

01.11.2018

Story

More and more resistant pathogens are spreading that cannot be harmed by traditional antibiotics. They are a great danger to the public health systems throughout the world. Without a major change in medical research and development, diseases that can be treated today may become incurable in just a few years. A small wound on a finger may suddenly turn life-threatening, since more and more bacteria become resistant to common antibiotics. The development of resistance is a natural effect of evolution. Resistance arises during the use of antibiotics as some bacteria that are immune to the medication due to genetic variance survive the treatment and then continue to proliferate. Meanwhile, the World Health Organization (WHO) considers antibiotic resistances to be one of the “major threats to global health and food safety”. They cause longer stays in hospital and therefore increasing costs of therapy and higher mortality. The spreading of resistances can be explained by a number of reasons, for example overly eager administration of antibiotics in the treatment of the symptoms of common colds, the use of antibiotics for insufficient periods of time or the improper use in animal husbandry. But one fact is clear: Solutions must be found rapidly by innovative research.

01.11.2018

HZI Campus

HIPS

Stefan Schmelz at his desk with 3D printer and laptop

Portrait

At outside temperatures of -10 °C, Stefan Schmelz, wearing a short-sleeved shirt, seems to have discovered an alternative energy source for himself. The postdoctoral fellow in the "Structure and Function of Proteins" department at the HZI would seem to need one to master all the tasks in his workday. He calls it a challenge – rather than a problem – to be working to capacity both at work and at home. The father of three small children knows exactly how important it is to be organised and to address tasks with an aim. "Time management is everything," he says. The large range of tasks entrusted to him in the department is impressive: He is responsible for the entire computer infrastructure and the major equipment as well as the X-ray room, the imagers and the crystallography units. Having to change his agenda is his everyday routine – and he is happy with it: He likes his work at the HZI and does not want the routine of an assembly line job.

01.11.2018

HZI Campus

News

The new “Helmholtz International Labs” programme will fund research projects covering new medicines for infections, the effects of environmental impacts on health, and unique insights into the structure of matter. These international labs will receive up to 300,000 euros annually for an initial period of five years. This will increase collaboration between the Helmholtz Association and excellent research institutions worldwide, as part of the Association’s internationalisation strategy.

18.10.2018

HZI Campus

Trypanosomen mit unterschiedlich angefärbten Oberflächenproteinen.

News

Trypanosoma brucei, which causes sleeping sickness, evades the immune system by repeatedly altering the structure of its surface coat. An international research team, including Dr Emmanuel Saliba from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, has now sequenced the complete genome of the parasite and studied its 3D genome architecture. By that, the researchers have revealed crucial molecular aspects of the pathogen’s molecular strategy. The new findings appear in the leading science journal Nature. The HIRI is a location of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg.

17.10.2018

HIRI

Back to the first page
...
74
75
76
77
...
148

HZI in the media

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025

MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025

innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025

Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025

Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025

PROCESS

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025

Bioengineer.org

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025

Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025

Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025

AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025

Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025

Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025

Apotheken Umschau

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.